We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLC:ASXLendlease Group Analysis

Data as of 2026-05-25 - not real-time

A$2.79

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Lendlease Group is trading at A$2.79, well below its 20‑day (A$3.12), 50‑day (A$3.24) and 200‑day (A$4.65) simple moving averages, with an RSI of 25 indicating oversold conditions and a bearish MACD histogram. High 30‑day volatility (≈30%) and a max drawdown of over 52% underscore a sharply deteriorating price momentum.
Fundamentally, the company posted a $318 million half‑year loss, with revenue contracting 37% year‑on‑year, negative operating and profit margins, and operating cash flow running at –A$833 million. Debt remains high at A$4.2 billion against cash of A$0.65 billion, yielding a debt‑to‑equity ratio above 75%, while ROE and ROA are both negative. Despite this, the forward P/E of 5.8 is dramatically lower than the industry average of 32.7, the price‑to‑book sits at 0.34 and the dividend yield is an elevated 8.3%, though earnings‑based sustainability is doubtful.
Given the confluence of bearish technical signals, severe earnings shortfall, and a precarious balance sheet, short‑term exposure is risky. However, the deep valuation discount and sizable asset base could present a value‑oriented upside if the restructuring and capital‑recycling initiatives bear fruit over the medium to long term.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Recent $318 million loss and negative cash flow
  • Bearish technical indicators (price below SMAs, MACD, RSI)
  • High volatility and widening drawdown

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant valuation discount relative to peers
  • Potential upside from capital recycling and restructuring
  • Uncertain dividend sustainability amid losses

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Deep value metrics (low P/E, low P/B, high dividend yield)
  • Asset‑rich business with diversified global exposure
  • Potential turnaround if debt reduction and operational improvements succeed

Key Metrics & Analysis

Financial Health

Revenue Growth-37.30%
Profit Margin-2.33%
P/E Ratio5.8
ROE-2.66%
ROA-0.10%
Debt/Equity75.51
P/B Ratio0.3
Op. Cash FlowA$-833000000
Free Cash FlowA$-811124992
Industry P/E32.7

Technical Analysis

TrendBearish
RSI25.2
SupportA$2.70
ResistanceA$3.40
MA 20A$3.12
MA 50A$3.24
MA 200A$4.65
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Target PriceA$5.04
Upside/Downside80.75%
GradeUndervalued
TypeValue
Dividend Yield8.30%

Risk Assessment

Beta0.25
Volatility30.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.